Kraig Biocraft Laboratories Announces Shareholder Conference Call Advisory
April 20 2011 - 6:05AM
Marketwired
Kraig Biocraft Laboratories, Inc. (PINKSHEETS: KBLB) announces an
advance conference call advisory for all shareholders and other
interested parties.
The Company plans to host a conference call for the purpose of
discussing corporate developments. The conference call is
tentatively scheduled for mid May and will feature the Company's
founder and CEO, Kim Thompson.
The Company plans on releasing definitive details, including
call-in details, time and format, at least a week prior to
conference call.
"The recent licensing agreement is accelerating corporate
activities, including laboratory evolution, and I look forward to
updating our shareholders and other interested parties," said
Thompson.
About Kraig Biocraft Laboratories
Kraig Biocraft Laboratories is a fully reporting biotechnology
company that recently achieved a series of scientific
breakthroughs, with implications for the global textile industry.
For further information please visit www.KraigLabs.com.
Statements in this press release about the company's future and
expectations other than historical facts are "forward-looking
statements." These statements are made on the basis of management's
current views and assumptions. As a result, there can be no
assurance that management's expectations will necessarily come to
pass. These forward-looking statements generally can be identified
by phrases such as "believes," "plans," "expects," "anticipates,"
"foresees," "hopes," "develops," "researching," "research,"
"potential," "implications," "could" or other words or phrases of
similar import. Similarly, statements in this release that describe
the Company's business strategy, outlook, objectives, plans,
intentions or goals should all be considered forward-looking
statements. All such forward-looking statements are subject to
certain risks and uncertainties that could cause actual results to
differ materially from those in forward-looking statements.
Management cautions that its ability to further its research, and
create commercially-viable products may be affected by the
competitive environment, the Company's financial condition and its
ability to raise sufficient capital to meet the financial
obligations of its business plan and to fund its continuing
operations.
Contact: Ben Hansel (720) 288-8495
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From May 2024 to Jun 2024
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Jun 2023 to Jun 2024